PARK7/DJ1 Antikörper
Kurzübersicht für PARK7/DJ1 Antikörper (ABIN2330391)
Target
Alle PARK7/DJ1 (PARK7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Rind (Kuh), Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Bo Hu Mo
-
Produktmerkmale
- PARK7 (CAP1, Oncogene DJ1, Parkinson Disease (Autosomal Recessive Early Onset) 7, RNA Binding Protein Regulatory Subunit, SP22)
-
Aufreinigung
- Purified by affinity chromatography.
-
Immunogen
- Full length recombinant human DJ-1 expressed in and purified from E. coli.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 10 mM sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))
-
Andere Bezeichnung
- PARK7
-
UniProt
- Q99497
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Proton Transport
Target
-